Edesa Biotech logo

Edesa BiotechNASDAQ: EDSA

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

21 June 2010

Next earnings report:

09 August 2024

Last dividends:

N/A

Next dividends:

N/A
$13.54 M
-91%vs. 3y high
20%vs. sector
-vs. 3y high
-vs. sector
-68%vs. 3y high
72%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | 48 min ago
$4.21-$0.58(-12.11%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

EDSA Latest News

Edesa Biotech to Participate in Barclays Global Healthcare Conference
Accesswire07 March 2024 Sentiment: NEUTRAL

TORONTO, ON / ACCESSWIRE / March 7, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that company management will participate in the Barclays 26th Annual Global Healthcare Conference, which is being held in Miami, Florida, from March 12-14, 2024. Attendees interested in meeting with Edesa can request meetings through conference organizers or by contacting the company at [email protected].

What type of business is Edesa Biotech?

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

What sector is Edesa Biotech in?

Edesa Biotech is in the Healthcare sector

What industry is Edesa Biotech in?

Edesa Biotech is in the Biotechnology industry

What country is Edesa Biotech from?

Edesa Biotech is headquartered in Canada

When did Edesa Biotech go public?

Edesa Biotech initial public offering (IPO) was on 21 June 2010

What is Edesa Biotech website?

https://www.edesabiotech.com

Is Edesa Biotech in the S&P 500?

No, Edesa Biotech is not included in the S&P 500 index

Is Edesa Biotech in the NASDAQ 100?

No, Edesa Biotech is not included in the NASDAQ 100 index

Is Edesa Biotech in the Dow Jones?

No, Edesa Biotech is not included in the Dow Jones index

When does Edesa Biotech report earnings?

The next expected earnings date for Edesa Biotech is 09 August 2024